April 2026 — The global veterinary antimicrobial susceptibility testing (AST) market is set for robust growth as the animal health industry intensifies efforts to combat antimicrobial resistance (AMR). Valued at USD 1.22 billion in 2025, the market is projected to reach USD 2.43 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7.97% during the forecast period.
Veterinary AST plays a crucial role in identifying the effectiveness of antimicrobial treatments against animal pathogens, supporting informed clinical decisions across livestock and companion animal care. Increasing regulatory focus, rising infection rates in intensive farming, and the need for responsible antibiotic use are driving widespread adoption of these diagnostic solutions.
Get the Complete Report Now with Exclusive Discount: https://straitsresearch.com/report/veterinary-antimicrobial-susceptibility-testing-market/request-sample
Rapid Diagnostics and Standardization Transform Market Landscape
A key trend shaping the market is the growing adoption of point-of-care AST platforms that deliver rapid results directly within veterinary clinics. These systems significantly reduce turnaround times, enabling veterinarians to make timely and precise treatment decisions without relying solely on centralized laboratories.
Simultaneously, the global shift toward standardized testing frameworks—such as harmonized EUCAST and CLSI veterinary protocols—is improving consistency and reliability in susceptibility testing. This standardization is encouraging laboratories to upgrade equipment, expand testing capabilities, and adopt automated systems.
Demand from Intensive Farming Accelerates Adoption
The expansion of large-scale livestock operations is a major driver of market growth. Producers in poultry, swine, and cattle sectors are increasingly implementing rapid AST solutions to manage disease outbreaks, reduce mortality, and optimize antimicrobial use.
Advanced systems capable of delivering quantitative results within hours are gaining traction, particularly in high-density farming environments where timely intervention is critical to maintaining productivity and animal health.
Regional Insights Highlight Strong Growth Potential
North America leads the global market, accounting for over 35% of total revenue in 2025. The region benefits from strong regulatory frameworks, well-established veterinary laboratory networks, and active participation in antimicrobial resistance surveillance programs.
Asia-Pacific is emerging as the fastest-growing region, with a projected CAGR of 9.42%. Growth is driven by expanding livestock industries, increasing export compliance requirements, and rising investments in veterinary diagnostic infrastructure across countries such as China and Australia.
Europe is also witnessing steady expansion, supported by coordinated antimicrobial resistance monitoring programs and standardized testing practices across veterinary laboratories.
Get the Complete Report Now with Exclusive Discount: https://straitsresearch.com/report/veterinary-antimicrobial-susceptibility-testing-market/request-sample
Emerging Opportunities in Data Integration and Surveillance
The integration of AST data into national and international AMR surveillance systems presents a significant growth opportunity. By contributing real-time resistance data, veterinary laboratories are supporting epidemiological monitoring and helping shape policy decisions related to antibiotic use in animal health.
Collaborations between diagnostic companies, government agencies, and research institutions are further strengthening data-sharing ecosystems and driving demand for connected, standardized testing platforms.
Challenges Impacting Market Expansion
Despite positive growth prospects, the market faces challenges related to the high cost and maintenance requirements of automated AST systems. These factors can limit adoption among smaller veterinary clinics and diagnostic centers, particularly in developing regions.
However, ongoing advancements in technology and the development of cost-effective solutions are expected to gradually address these barriers.
Competitive Landscape and Innovation Focus
The veterinary AST market is moderately fragmented, with leading players focusing on technological innovation, automation, and expanded product portfolios. Companies are investing in AI-driven platforms, rapid testing solutions, and integrated data systems to enhance diagnostic accuracy and efficiency.
Emerging players are also introducing next-generation solutions designed to deliver faster results and improve workflow efficiency, contributing to a more dynamic and competitive market environment.
Future Outlook
As antimicrobial resistance continues to pose a global challenge, veterinary antimicrobial susceptibility testing will play an increasingly vital role in ensuring responsible antibiotic use and safeguarding animal and public health. Advances in rapid diagnostics, data integration, and standardized testing are expected to drive sustained market growth in the coming years.
About the Market
The veterinary antimicrobial susceptibility testing market includes a range of diagnostic tools and technologies used to evaluate the effectiveness of antimicrobial agents against animal pathogens. These solutions are widely utilized in veterinary laboratories, research institutes, and animal healthcare facilities to support disease management, treatment optimization, and resistance monitoring across both production and companion animals.
https://sites.google.com/view/foodandbeveragesresearchreport/home/food-texture-market
